Search clinical trials for: 21ug MAP0020

Total 40 results

Allergan
MAP Pharmaceuticals, Inc., a wholly owned subsidiary of Allergan

Completed

Tolerability and PK of Submicron Budesonide in Children 4 to 11 Years Old With Mild-To-Moderate Stable Asthma

Asthma

United States
Quratis Inc.

Active, not recruiting

Study to Assess Safety, Reactogenicity and Immunogenicity of the repRNA(QTP104) Vaccine Against SARS-CoV-2(COVID-19)

COVID-19 | SARS-CoV-2

Korea, Republic of
Allergan
MAP Pharmaceuticals, Inc., a wholly owned subsidiary of Allergan

Completed

Study of MAP0010 in Asthmatic Children and Adolescents

Asthma

United States
Allergan
MAP Pharmaceuticals, Inc., a wholly owned subsidiary of Allergan

Completed

A Study of 2 Doses of MAP0010 and Placebo in Asthmatic Children

Asthma
Allergan
MAP Pharmaceuticals, Inc., a wholly owned subsidiary of Allergan

Terminated

A Study of 2 Doses of MAP0010 in Asthmatic Children

Asthma
University of Surrey

Completed

A Study to Characterise Immune Responses Following Immunisations With "Fendrix" or "Engerix B" Hepatitis B Vaccines

Hepatitis B

United Kingdom
Allergan
MAP Pharmaceuticals, Inc., a wholly owned subsidiary of Allergan

Completed

Phase 3 Study of MAP0004 in Adult Migraineurs (FREEDOM301)

Migraine Disorders

United States
Novartis Pharmaceuticals
Molecular Partners AG

Terminated

A Dose Finding, Efficacy and Safety Study of Ensovibep (MP0420) in Ambulatory Adult Patients With Symptomatic COVID-19 (EMPATHY)

COVID-19

United States, India, Hungary, Netherlands, South Africa
Allergan
MAP Pharmaceuticals, Inc., a wholly owned subsidiary of Allergan; Q-Pharm Pty...

Completed

Safety and Blood Level Study of Unit Dose Budesonide (UDB P101)

Asthma

Australia
Molecular Partners AG

Completed

Viral Clearance, PK and Tolerability of Ensovibep in COVID-19 Patients

Covid19

Netherlands
Imperial College London
AstraZeneca

Completed

Effect of Symbicort ® on GR in Sputum in COPD

Chronic Obstructive Lung Disease

United Kingdom
Molecular Partners AG

Terminated

Safety, Tolerability and PK of Ensovibep (MP0420 - a New Candidate With Potential for Treatment of COVID-19)

COVID-19

United Kingdom
Heidelberg University
Olympus Corporation

Unknown

EBUS-TBNA vs Flex 19G EBUS-TBNA

Lymphoma | Lung Cancer | Lymphadenopathy | Sarcoidosis

Germany
Royal Brompton & Harefield NHS Foundation Trust
Olympus Corporation

Completed

EBUS-TBNA vs Flex 19G EBUS-TBNA

Lymphoma | Lung Cancer | Lymphadenopathy | Sarcoidosis

United Kingdom
Allergan
MAP Pharmaceuticals, Inc., a wholly owned subsidiary of Allergan

Completed

A Study of 2 Doses of MAP0010 in Adult Asthmatics (P202)

Asthma

United States
Baxalta now part of Shire
Takeda Development Center Americas, Inc.

Recruiting

A Study of Recombinant Von Willebrand Factor (rVWF) in Pediatric and Adult Participants With Severe Von Willebrand Disease (VWD)

Von Willebrand Disease (VWD)

United States, Italy, Spain, Netherlands, Turkey, France, Austria, Germany, Russian Federation
SK Bioscience Co., Ltd.
GlaxoSmithKline; International Vaccine Institute; Coalition for Epidemic Preparedness...

Completed

Immunogenicity and Safety Study of SK SARS-CoV-2 Recombinant Nanoparticle Vaccine (GBP510) Adjuvanted With AS03 (COVID-19)

Covid19

Thailand, Korea, Republic of, New Zealand, Philippines, Ukraine, Vietnam
Korea University Guro Hospital
Korean Center for Disease Control and Prevention

Active, not recruiting

Safety, Reactogenicity, and Immunogenicity Study of Heterologous Booster Vaccination of a SARS-CoV-2 Recombinant Protein Nanoparticle Vaccine (GBP510)

COVID-19 (Healthy Volunteers)

Korea, Republic of
Fundacion para la Investigacion Biomedica del Hospital...

Completed

Bryostatin-1 Effect on HIV-1 Latency and Reservoir in HIV-1 Infected Patients Receiving Antiretroviral Treatment (BRYOLAT)

HIV Infection

Spain
National Institute of Allergy and Infectious Diseases...
National Heart, Lung, and Blood Institute (NHLBI); University of Copenhagen; US... and other collaborators

Completed

MP0420 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

COVID-19

United States, Denmark, Greece, Nigeria, Poland, Singapore, Spain, Switzerland, Uganda, United Kingdom
Washington University School of Medicine
Olympus

Recruiting

Thin and Ultrathin Bronchoscopy With Transbronchial Needle Aspiration and Radial Probe Endobronchial Ultrasound for Peripheral Pulmonary Lesions

Peripheral Pulmonary Nodules

United States
Pharmosa Biopharm Inc.
PPD

Completed

Single Ascending Dose Study for Evaluation of Safety, Tolerability and Pharmacokinetics of L606

Pulmonary Arterial Hypertension

United States
U.S. Army Medical Research and Development Command
Walter Reed Army Institute of Research (WRAIR)

Completed

Safety and Immunogenicity Study of Group B Meningococcal Vaccine to Prevent Meningitis.

Meningitis, Meningococcal, Serogroup B

United States
University of Chicago
National Institute on Drug Abuse (NIDA)

Completed

Mood Effects of Serotonin Agonists Extended (MESA-E)

Healthy

United States
Novartis Pharmaceuticals

Recruiting

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Glycopyrronium (Bromide) in Children (6 to Less Than 12 Years) With Asthma

Asthma

Spain, Hungary, United Kingdom, South Africa, Colombia, Bulgaria, Poland, Guatemala
The Queen Elizabeth Hospital
University of Adelaide; University of South Australia; Basil Hetzel Institute... and other collaborators

Completed

Evaluation of Transdermal Nicotine Replacement Therapy (NRT) Activity Through Metabolic Induction

Smoking | Addiction

Australia
Wageningen University
DSM Nutritional Products, Inc.; Top Institute Food and Nutrition

Completed

The Effect of Calcifediol (Hy.D 25 SD/S) and Vitamin D3 on Muscle Strength in a Frail Elderly Population (D-Fit)

Elderly, Frail | Deficiency, Vitamin D

Netherlands
Allergan
MAP Pharmaceuticals, Inc., a wholly owned subsidiary of Allergan

Completed

QT Intervals Study to Compare the Acute Effects of Orally Inhaled Dihydroergotamine (DHE), Oral Moxifloxacin, and Placebo

Healthy

United States
Allergan
MAP Pharmaceuticals, Inc., a wholly owned subsidiary of Allergan

Completed

Pharmacokinetics & Tolerability Study of MAP0004 in Smoking and Non-Smoking Adult Volunteers

Healthy Subjects

United Kingdom
Brown University
National Cancer Institute (NCI)

Recruiting

Preloading With Nicotine Replacement Therapy in HIV-positive Smokers to Improve Self-Efficacy and Quit Attempts

Tobacco Use Cessation

United States
Azhar University

Completed

Value of IPACK Block (Interspace Between the Popliteal Artery and Capsule of Knee) With Spinal Anesthesia Versus Fentanyl Based Spinal Anesthesia for Knee Arthroscopic Meniscectomy

Post Operative Pain

Egypt
Yale University
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Do Treatments for Smoking Cessation Affect Alcohol Drinking? Study 1: Nicotine Replacement Therapy

Alcohol Drinking

United States
National Institute of Allergy and Infectious Diseases...
Eli Lilly and Company; National Heart, Lung, and Blood Institute (NHLBI); Gla... and other collaborators

Completed

ACTIV-3: Therapeutics for Inpatients With COVID-19 (TICO)

Covid19

United States, Denmark, Greece, Nigeria, Poland, Singapore, Spain, Switzerland, Uganda, United Kingdom
Ottawa Heart Institute Research Corporation
Heart and Stroke Foundation of Ontario

Completed

Self-directed Titrated Transdermal Nicotine Patch Versus Standard Treatment for Smoking Cessation (STEP)

Smoking Cessation

Canada
SanQing Jin

Completed

Observation of Propofol Titration at Different Speeds (OPTDS)

Anesthesia, General | Hemodynamics

China
Seoul National University Hospital

Completed

Postoperative Analgesic Effect of Subcostal TAPB for Laparoscopic Gastrectomy

Postoperative Pain

Korea, Republic of
Assiut University

Recruiting

Non-invasive Carbon Dioxide Monitoring and Endoscopic Retrograde Cholangiopancreatography Patients

Patient Monitoring

Egypt
Allergan
MAP Pharmaceuticals, Inc., a wholly owned subsidiary of Allergan

Completed

Pharmacodynamic Study to Compare Acute Effects of Dihydroergotamine Mesylate (DHE) on Pulmonary Arterial Pressure

Healthy

United States
Allergan
MAP Pharmaceuticals, Inc., a wholly owned subsidiary of Allergan

Completed

Pharmacokinetics & Tolerability Study of MAP0004 Co-administered With Ketoconazole

Healthy

United Kingdom
Far Eastern Memorial Hospital
Research Ethics Review Committee

Unknown

Comparing Treatment Efficacy With High and Medium Dose of Fluticasone in Combination With Salmeterol in COPD Patients

Quality of Life | Percentage of Annual Acute Exacerbation

Taiwan

Search clinical trials for: 21ug MAP0020

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hong Kong

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations